|
|
||||||||
1 Laboratory of Molecular and
Integrative Urology, The lack of selective gap junctional uncoupling
agents has hampered evaluation of the contribution of intercellular
communication to pharmacomechanical coupling and vascular
contractility. Thus we further explored the utility and selectivity of
heptanol as a gap junctional uncoupling agent in isolated rat aortic
rings. Fifty-two aortic rings were obtained from 15 rats and were
precontracted to ~75% of maximum with phenylephrine (PE). When
contraction achieved steady state (~5 min), a single concentration of
heptanol (200 µM) was added to each aortic ring at 1- to 3-min
intervals for up to 42 min post-PE addition. At early time points
(5-10 min after PE), heptanol elicited an ~50% loss of tension
(i.e., relaxation). At subsequent time points post-PE, a gradual and
time-dependent decrease in the magnitude of the heptanol-induced
relaxation was observed until, after ~40 min, addition of heptanol
was associated with little, if any, detectable relaxation. Linear
regression analysis of the magnitude of the heptanol-induced relaxation
vs. the square root of the elapsed time interval (from addition of PE)
revealed a highly significant negative correlation
(P < 0.001, R = 0.81). Studies conducted on
KCl-precontracted aortic rings revealed no detectable heptanol-induced
relaxation after development of the steady-state KCl-induced
contraction. These data extend our previous observations to further
document the potential utility of heptanol as a "relatively
selective" uncoupling agent.
vascular smooth muscle; rat aortic rings; phenylephrine; pharmacomechanical coupling
AS REVIEWED ELSEWHERE recent publications have
established the fact that neither release of transmitter from
perivascular innervation nor regenerative electrical events (i.e.,
propagated action potentials) coordinate responses among vascular
smooth muscle cells in the majority of blood vessels (16). In
particular, it is quite clear that diffusion distances,
neurotransmitter volatility, tissue tortuosity factors, and neuronal
and nonneuronal uptake processes make it unlikely that neurotransmitter
concentrations would be sufficient to activate all of the smooth muscle
cells throughout the wall of the blood vessel, independent of other mechanisms (2, 4, 16, 24). In light of these considerations and the
fact that gap junctions have been identified between vascular wall
cells throughout the vasculature, the existence of a physiologically relevant intercellular pathway for coordinating syncytial vascular smooth muscle responses has long been suspected.
In fact, it has now become clear that intercellular communication
through gap junctions is important to the modulation of smooth muscle
tone at all levels of the vascular tree. More specifically, the gap
junction protein connexin 43 and to a much lesser extent connexin 40 appear to be the most frequently observed gap junction proteins present
between vascular smooth muscle cells. Several studies have provided
quite compelling, albeit often indirect, evidence for the importance of
the related intercellular channels to the initiation, maintenance, and
modulation of vascular smooth muscle tone (3, 8-16, 40, 41).
However, a more precise determination of the contribution of
intercellular channels to vascular function clearly awaits the advent
of more "specific" gap junctional uncoupling agents.
In this regard, multiple experimental attempts have been made to
identify selective gap junctional uncoupling agents (1, 5-9,
13-23, 25, 27, 29-44). A truly structurally diverse group of
inhibitors has been examined, and, not surprisingly, some degree of
lipophilicity is an apparent prerequisite to junctional uncoupling. A
partial list of tested compounds includes
1) volatile general anesthetic
agents (e.g., halothane; see Refs. 7, 34, 44); 2) long-chain alcohols (e.g.,
heptanol and octanol; see Refs. 1, 9, 13-16, 21, 28, 30, 33, 34,
37, 38, 40, 42-44); 3)
organochlorine pesticides (19); 4)
derivatives of glycyrrhizic acid (e.g., 18 Despite encouraging progress, it is clear that, with the possible
exception of the peptide antibodies, demonstrative proof for specific
junctional uncoupling agents, at the tissue level, remains largely
elusive. This fact continues to obfuscate a more precise evaluation of
the contribution of gap junctions to vascular function both in vitro
and in vivo. However, with respect to the former, an algorithm for
maximizing the observed selectivity (or at least increasing the
"window of opportunity") of more nonspecific agents, in
particular, heptanol, has been advanced (9, 13, 15). Thus it was the
explicit goal of the current study to extend the scope of previous
investigations to further evaluate the potential utility of heptanol as
a "relatively selective" gap junctional uncoupling agent, while
simultaneously exploring the role of intercellular communication in
modulating Tissue preparation. A total of 52 isolated rat aortic rings were prepared from 15 Fisher-344 rats
(10-12 wk old). Briefly, the aorta was denuded of endothelium by
gentle rubbing of the intimal surface with a stainless steel wire as
previously described (9, 13). Three to four aortic rings ~5 mm in
length were obtained from each rat. Rings were immediately placed in
ice-cold Krebs-Henseleit buffer containing (in mM) 110 NaCl, 4.8 KCl,
2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4,
25 NaHCO3, and 11 dextrose in
double-distilled water. Aortic rings were suspended between two
fishhooks and were placed in jacketed isolated 20-ml organ bath
chambers with fresh Krebs-Henseleit buffer. Organ bath chambers were
maintained at 37 ± 0.05°C and were continuously bubbled with
95% O2 and 5%
CO2 to maintain a pH = 7.4 ± 0.01. Aortic rings were initially set between 2 and 3 g of basal
tension, washed periodically with fresh buffer, and allowed to
equilibrate at 37°C over a period of ~90 min. Contractions were
measured isometrically with a Grass Force Displacement Transducer
(model FT-03) and were recorded on a Grass Polygraph (models 7E or 7F).
Protocol design. In all experiments
(52 rings from 15 animals), rat aortic rings were precontracted to 75%
of maximum with either PE (200 nM) or KCl (60 mM). When the contractile
response achieved steady state (~5 min after PE or KCl was added), a
single concentration of heptanol
[EC50 200 µM as previously
reported (9, 13)] was added to each aortic ring at 1- to 3-min
intervals for up to 42 min after PE was initially added.
Data analysis. Linear regression
analysis of the magnitude of the heptanol-induced relaxation response
vs. time elapsed after addition of PE was performed. Unless otherwise
stated, all data are expressed as means ± SE.
Differential heptanol-induced relaxation of rat aortic
rings precontracted with PE or KCl. Figure
1 shows a representative example of the
effect of heptanol on both PE- and KCl-precontracted rat aortic rings.
As illustrated, PE or KCl was added to the aortic ring preparation, and
the contractile response was allowed to achieve steady state. After
achievement of the steady-state response, a single concentration of
heptanol was added to the aortic ring, and the ensuing relaxation
caused a loss in tension. As shown, addition of 200 µM heptanol
5-10 min post-PE was associated with a rapid, robust, and
reproducible relaxation response in all aortic rings examined. In stark
contrast to observations on PE-precontracted aortic rings, there was a
complete absence of any detectable effect of heptanol on the magnitude
of the KCl-induced contractile response in rat aortic rings. As
illustrated in Fig. 1A, heptanol had
little or no detectable effect on the magnitude of the KCl-induced
contractile response in rat aortic rings. Importantly, this was also
the case even when the measured KCl-induced tension was as little as
600 mg. The results of several similar experiments, conducted on
distinct KCl-precontracted aortic rings, are summarized in Table
1. Figure 1B shows that the PE-induced
contractile response is stable over the entire time course of the
experimental protocol.
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-glycyrrhetinic acid; an
aglycone of glycyrrhizic acid, a saponin obtained from the licorice
root Glycyrrhizia glabra; see Ref. 19);
5) fatty acids (e.g., arachidonic acid, oleic acid, linoleic acid, palmitic acid, etc.; see Refs. 5, 17,
23, 31); and 6) SKF-525A, a blocker
of cytochrome P-450 enzymes (39). More
recently, peptide antibodies directed toward the extracellular loops of
connexin 43 have been developed in the hope that perhaps
connexin-specific disruption of connexon hemichannel
docking in the extracellular space will provide a strategy for the
selective disruption of the intercellular pathway (9).
-adrenergic contractions in vasculature. To this end, we
examined the effects of heptanol on the magnitude of steady-state
phenylephrine (PE)- and KCl-induced contractile responses in isolated
rat aortic rings and compared those effects with the effects of
heptanol during the transient, diffusion-limited phase of PE-induced
contractile responses.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES


View larger version (24K):
[in a new window]
Fig. 1.
Reproduction of original tracings depicting the experimental paradigm
and representative examples of the effects of heptanol on the magnitude
of roughly equivalent phenylephrine (PE)- and KCl-induced steady-state
contractile responses in distinct rat aortic rings
(A). Results displayed in
B illustrate that the PE (200 nM)-induced contractile response is stable over the entire duration of
the experimental protocol.
Table 1.
Effect of heptanol on the KCl-induced steady-state contractile response
in several distinct rat aortic rings
Time-dependent nature of heptanol-induced relaxation
of PE-precontracted rat aortic rings. Figure
2 illustrates representative tracings of
the effects of heptanol on the magnitude of the PE-induced contractile
response 7, 15, 24, 30, and 40 min after the addition of PE. Note the
gradual and time-dependent decline in the magnitude of the
heptanol-induced relaxation response; until ~40 min after the
addition of PE to the aortic ring preparation, there was little or no
detectable effect of heptanol on the magnitude of the PE-induced steady-state contractile response. Data collected from
several experiments on distinct aortic rings were pooled for each time point and subsequently plotted as the empirically determined
heptanol-induced percent relaxation vs. the total time elapsed after
the addition of PE to the organ bath chamber. As shown in Fig.
3, linear regression analysis revealed a
highly statistically significant negative correlation
(P < 0.001;
R = 0.81). Figure
4 shows a further representative example of
the completely reversible and time-dependent nature of the
heptanol-induced relaxation response. As illustrated, addition of
heptanol elicited an ~50% relaxation response. Note, however, that
within 20 min the contractile tension still returns to the preheptanol
value, nominally in the continued presence of both heptanol and PE.
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Heptanol is a long-chain alcohol originally utilized as a gap junctional uncoupling agent in dual whole cell patch-clamp experiments to decrease the macroscopic conductance between cell pairs and permit visualization of unitary channel events. Under such conditions, there is little question that heptanol can completely and reversibly uncouple isolated cell pairs. More recently, the use of heptanol has been extended to assess the role of intercellular communication in mediating a variety of responses in multicellular preparations (9, 11-16, 30, 38, 40). It is in this latter scenario that the mechanism of action becomes particularly critical.
In this regard, the exact mechanism of action of heptanol is still not known. However, it is thought to be related to decreased fluidity of cholesterol-rich membrane domains, resulting in a reduced open probability of the gap junction channel (1, 7, 36). Any selectivity of heptanol therefore would presumably reside in preferential intercalation at the gap junction protein/lipid interface, thus eliciting conformational changes that "gate" the gap junctional channels closed.
Without question, this highly lipophilic anesthetic agent lacks
specificity at high concentrations (i.e., concentrations
1-2 mM). Therefore, heptanol will undoubtedly exhibit
concentration-dependent actions on many aspects of cellular function
that are unrelated to its gap junctional effects. Such considerations
are of particular significance to the current studies, because there
are many steps between receptor activation and generation of the
contractile response in isolated rat aorta. A prerequisite to the
utilization of heptanol as an uncoupling agent is identification of a
relatively selective uncoupling action.
In fact, an algorithm for identifying reasonable experimental conditions under which heptanol may be utilized as a relatively selective uncoupling agent have been codified (9). Briefly, it was posited that heptanol concentrations that elicit ~50% relaxation in a tissue precontracted to ~75% of its maximum had a predominant, although not exclusive, action on junctional conductance. The rationale and evidence supporting this supposition have been outlined in great detail elsewhere (9, 13, 15). An explicit aim of this study, therefore, was to expand the scope of these previous investigations to further elaborate on the potential utility of heptanol as a relatively selective gap junctional uncoupling agent.
In this regard, the major new finding of this study is the observation
that the ability of heptanol to elicit relaxation of PE-precontracted,
but not KCl-precontracted, rat aortic rings is time dependent (Figs.
1-3) and, moreover, independent of the order of addition of PE or
heptanol (Figs. 4 and 5). More
specifically, immediately after achievement of a steady-state
PE-induced contractile response, application of heptanol to aortic
rings produces an ~50% loss of measured tension (i.e., relaxation;
see Fig. 1). For all subsequent time points, the greater the elapsed
time interval between addition of PE to the aortic rings and the
application of heptanol, the smaller the observed relaxation response
(Fig. 2). Consistent with this latter result, linear regression
analysis revealed a highly significant negative correlation between
this time interval and the percent relaxation of PE-precontracted
aortic rings (Fig. 3). In fact, ~40 min after the addition of PE, the application of heptanol produced little or no detectable effect on the
magnitude of the PE-induced steady-state contractile response. In
addition, at no point in time did heptanol ever elicit a detectable relaxation response on KCl-precontracted tissues (Table 1), even when
the measured tension was as little as 600 mg (see RESULTS). Finally, even when the heptanol-induced relaxation response was ~50%, within 20 min the contractile tension still returns to the preheptanol value (Fig. 4), nominally in the continued presence of both
heptanol and PE. Because the heptanol was added 12 min after addition
of PE in this experiment and the contractile response returned to the
"preheptanol" level in ~20 min, these data are also consistent
with the estimated time course of PE diffusion through the
extracellular space (see below).
|
Before interpreting the results of these experiments, it is important to first consider the spectrum of hypothesized nonjunctional activities of heptanol. This spectrum includes, but is not limited to, the following: 1) gating effects on nonjunctional ion channels (e.g., calcium, potassium, and sodium), 2) effects on second messenger molecule formation/turnover/diffusion, 3) alterations in myofilament calcium sensitivity, 4) changes in the degree of myosin phosphorylation, etc. Most, if not all, of these processes contribute to the tonic portion of smooth muscle contraction. Thus, if heptanol had a major action on smooth muscle tone that was unrelated to its activity on gap junctions, application of heptanol should universally alter the amplitude of the PE-induced contractile response, regardless of the elapsed time from addition of PE. Certainly, this was not the case in the present experiments (see Figs. 1-4).
As elaborated elsewhere (9, 13, 15), the fact that heptanol had no
detectable effect on the magnitude of the KCl-induced contractile
response, even at extremely low levels of contractility, is also
inconsistent with the presence of a significant nonjunctional action.
That is, the KCl-induced contractile response is accompanied by lower
levels of myosin phosphorylation and tension development per unit
increase in intracellular calcium levels than agonist-induced contractions (i.e.,
-adrenergic responses; see Ref. 26). Thus, if
heptanol altered any aspect of myofilament calcium sensitization or
myosin light chain phosphorylation, KCl-induced contractile responses,
which are inherently less efficient with respect to second messenger
formation/sensitization, should be disproportionately affected by
heptanol. Such was not the case, even when the amplitude of the
KCl-induced stimulus/contractile response was exceedingly low (i.e.,
<600 mg).
The observations of others also support the possibility of
"selective" uncoupling actions for heptanol. By and large, the nonjunctional actions of heptanol on sodium, potassium, and calcium channels in cardiac and smooth muscle myocytes are observed at heptanol
concentrations
1-2 mM (21, 32, 35, 37). The recent findings of
Garcia-Dorado and co-workers (21) support the plausibility of a
concentration-dependent separation of the junctional and nonjunctional
actions of heptanol. Specifically, they showed that relatively
selective junctional effects occurred at concentrations ranging from 30 to 300 µM, whereas nonjunctional effects occurred at heptanol
concentrations from 1 to 3 mM. Other studies have suggested, but not
proven, that heptanol might alter calcium channel activity in
gastrointestinal smooth muscle at concentrations as low as 0.5 mM (35)
or in rabbit mesenteric artery at concentrations
300 µM (9).
Conversely, studies in guinea pig vas deferens have provided evidence
for selective disruption of intercellular communication among smooth
muscle cells at concentrations ranging from 500 µM to 2 mM (30). Such
differences emphasize the importance of utilizing heptanol on a
case-by-case basis, as originally proposed (9). However, taken
together, the current weight of experimental evidence indicates that
the heptanol concentration used here (200 µM) would be expected to
elicit minimal perturbation of nonjunctional ion channels, coupled with
minor effects on myocyte contractility [perhaps
5-10% as
reported by Garcia-Dorado et al. (21) compared with the 50% relaxation
observed at the earlier time points, for example].
If heptanol has a relatively selective action on junctional
communication, then one cogent interpretation of our data is that the
time-dependent effects of heptanol reflect the time course of PE
diffusion through the extracellular space of the aortic media. Clearly
these studies did not directly address this possibility, but the
specific rationale is as follows. As PE diffuses through the medial
smooth muscle layer(s) it will gradually activate all possible
responsive cells (Fig. 5). When PE has directly activated all of the
smooth muscle cells that are capable of responding (i.e., cells that
have functionally coupled
-adrenergic receptors), the observed
contractile response will nominally be independent of intercellular
communication. As illustrated in Fig.
5C, at this point in
time, the magnitude of the steady-state response would be expected to
be the same whether the smooth muscle cells were directly (i.e., a cell
contracts subsequent to PE activation of its
-adrenergic receptor)
or indirectly [i.e., a cell is activated by the intercellular
diffusion of relevant second messenger molecules/ions (e.g., calcium,
inositol trisphosphate, or diacylglycerol)] activated by PE.
Despite the requisite assumptions, and numerous possible diffusion
paths, it is still worth considering what the time-dependent nature of
the effects of heptanol on the steady-state contractile responses to
both PE and KCl might indicate about the expected extracellular
diffusion profiles of these compounds, under these conditions. That is,
let us assume that the homogeneous
EC50 distribution of KCl or PE
(i.e., one-half of the molecules) throughout the vessel wall is roughly
correlated with the achievement of the steady-state contractile
response. In light of this explicit assumption, one can make
approximate calculations using a simple linear diffusion equation of
the following form (29):
(x)2/t=Dapp,
where x, the diffusion distance for
the one-half concentration, is 50-100 µM [assuming that
there may be (to varying degrees) luminal and/or adventitial diffusion
through the ~100 µM thickness of the rat aorta (13)],
t is time, and
Dapp is the
apparent diffusion coefficient. As such, we calculated
Dapp to be in the range of ~1-3 × 10
7
cm2/s for KCl (~5 min or 300 s
after addition of KCl; see Fig. 1) and ~2-4 × 10
8
cm2/s for PE (40 min or 2,400 s
after addition of PE; see Fig. 3). Clearly, the representative example
illustrated in Fig. 4 further bolsters such a hypothesis and shows that
the regaining of tension after the addition of heptanol to the
precontracted aortic ring is also consistent with the time course for
the estimated diffusion of PE through the extracellular space (i.e.,
~12 min of preincubation and ~20 min to regain tension).
Finally, it is relevant to consider the potential implication of these in vitro observations to the in vivo environment. This report clearly documents that, in the presence of sufficiently high agonist concentrations (i.e., the saturating and stable PE concentrations provided in the organ bath chamber) for adequately long time intervals (~40 min), PE can directly activate all of the vascular smooth muscle cells that contribute to the contractile response. Under such conditions, the PE-induced contractile response in vitro is clearly independent of junctional communication. However, because alterations in smooth muscle tone in vivo are continuously modulated by the dynamically changing hormonal milieu, it is unlikely that either of these two conditions (i.e., saturating and stable drug concentrations) is consistently met in vivo. Thus it would seem that intercellular communication through gap junctions in vivo would play an absolutely critical role in the initiation, maintenance, and modulation of smooth muscle tone. Certainly an unequivocal affirmation of this hypothesis awaits verification in vivo.
In conclusion then, there are two important physiological implications of the current observations. First, as previously hypothesized (9, 13, 15, 16), these data provide the most compelling evidence yet that, under appropriate experimental conditions, heptanol can indeed be used as a relatively selective, as well as a readily reversible, gap junctional uncoupling agent. Second, having explicitly accepted the verity of the first supposition, it is clear that intercellular communication through gap junctions is likely to play a very prominent role in pharmacomechanical coupling and vascular contractility in vivo.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported in part by National Institutes of Health Grants DK-46379 (to G. J. Christ) and HL-31299 (to P. R. Brink).
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for correspondence and reprint requests: G. J. Christ, Laboratory of Molecular and Integrative Urology, Rm. 744, Forchheimer Bldg., 1300 Morris Park Ave., Bronx, NY 10461 (E-mail: christ{at}aecom.yu.edu).
Received 6 July 1998; accepted in final form 12 February 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bastiaanse, E. M.,
H. J. Jongsma,
A. van der Laarse,
and
B. R. Takens-Kwak.
Heptanol-induced decrease in cardiac gap junctional conductance is mediated by a decrease in the fluidity of membranous cholesterol-rich domains.
J. Membr. Biol.
136:
135-145,
1993[Medline].
2.
Bevan, J. A.,
and
J. Torok.
Movement of norepinephrine through the media of rabbit aorta.
Circ. Res.
27:
325-331,
1970
3.
Brink, P. R.,
S. V. Ramanan,
and
G. J. Christ.
Human connexin 43 gap junction channel gating: evidence for mode shifts and/or heterogeneity.
Am. J. Physiol.
271 (Cell Physiol. 40):
C321-C331,
1996
4.
Burnstock, G.
Structure of smooth muscle and its innervation.
In: Smooth Muscle, edited by E. Bulbring,
A. F. Brading,
A. W. Jones,
and T. Tomita. Baltimore, MD: . Williams and Wilkins, 1970, p. 1-69.
5.
Burt, J. M.
Uncoupling of cardiac cells by doxyl stearic acids specificity and mechanism of action.
Am. J. Physiol.
256 (Cell Physiol. 25):
C913-C924,
1989
6.
Burt, J. M.,
K. D. Massey,
and
B. N. Minnich.
Uncoupling of cardiac cells by fatty acids: structure-activity relationships.
Am. J. Physiol.
260 (Cell Physiol. 29):
C439-C448,
1991
7.
Burt, J. M.,
and
D. C. Spray.
Volatile anesthetics block intercellular communication between neonatal rat myocardial cells.
Circ. Res.
65:
829-837,
1989
8.
Chaytor, A. T.,
W. H. Evans,
and
T. M. Griffith.
Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries.
J. Physiol. (Lond.)
503:
99-110,
1997[Medline].
9.
Christ, G. J.
Modulation of
1-adrenergic contractility in isolated vascular tissues by heptanol: a functional demonstration of the potential importance of intercellular communication to vascular response generation.
Life Sci.
56:
709-721,
1995[Medline].
10.
Christ, G. J.
The "syncytial tissue triad": a model for understanding how gap junctions participate in the local control of penile erection.
World J. Urol.
15:
36-44,
1997[Medline].
11.
Christ, G. J.,
P. R. Brink,
A. Melman,
and
D. C. Spray.
The role of gap junctions and ion channels in the modulation of electrical and chemical signals in human corpus cavernosum smooth muscle.
Int. J. Impot. Res.
5:
77-96,
1993[Medline].
12.
Christ, G. J.,
P. R. Brink,
and
S. V. Ramanan.
Dynamic gap junctional communication: a delimiting model for tissue responses.
Biophys. J.
67:
1335-1344,
1994
13.
Christ, G. J.,
P. R. Brink,
W. Zhao,
J. Moss,
C. M. Gondre,
C. Roy,
and
D. C. Spray.
Gap junctions modulate tissue contractility and
1-adrenergic agonist efficacy in isolated rat aorta.
J. Pharmacol. Exp. Ther.
266:
1054-1065,
1993
14.
Christ, G. J.,
A. P. Moreno,
A. Melman,
and
D. C. Spray.
Gap junction-mediated intercellular diffusion of Ca2+ in cultured human corporal smooth muscle cells.
Am. J. Physiol.
263 (Cell Physiol. 32):
C373-C383,
1992
15.
Christ, G. J.,
A. P. Moreno,
M. E. Parker,
C. M. Gondre,
M. Valcic,
A. Melman,
and
D. C. Spray.
Intercellular communication through gap junctions: a potential role in pharmacomechanical coupling and syncytial tissue contraction in vascular smooth muscle isolated from the human corpus cavernosum.
Life Sci.
49:
195-200,
1991.
16.
Christ, G. J.,
D. C. Spray,
M. el-Sabban,
L. K. Moore,
and
P. R. Brink.
Gap junctions in vascular tissues. Evaluating the role of intercellular communication in the modulation of vasomotor tone.
Circ. Res.
79:
631-646,
1996
17.
Cooklin, M.,
W. R. Wallis,
D. J. Sheridan,
and
C. H. Fry.
Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy.
Circ. Res.
80:
765-771,
1997
18.
Daniel, E. E.
Vascular gap junctional communication and heptanol.
Hypertension
30:
306,
1997.
19.
Davidson, J. S.,
and
I. M. Baumgarten.
Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships.
J. Pharmacol. Exp. Ther.
246:
1104-1107,
1988
20.
Deleze, J.,
and
J. C. Herve.
Effect of several uncouplers of cell-to-cell communication on gap junction morphology in mammalian heart.
J. Membr. Biol.
74:
203-215,
1983[Medline].
21.
Garcia-Dorado, D.,
J. Inserte,
M. Ruiz-Meana,
M. A. Gonzalez,
J. Solares,
M. Julia,
J. A. Barrabes,
and
J. Soler-Soler.
Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion.
Circulation
96:
3579-3586,
1997
22.
Guan, X.,
B. F. Cravatt,
G. R. Ehring,
J. E. Hall,
D. L. Boger,
R. A. Lerner,
and
N. B. Gilula.
The sleep-inducing lipid oleamide deconvolutes gap junction communication and calcium wave transmission in glial cells.
J. Cell Biol.
139:
1785-1792,
1997
23.
Hirschi, K. K.,
B. N. Minnich,
L. K. Moore,
and
J. M. Burt.
Oleic acid differentially affects gap junction-mediated communication in heart and vascular smooth muscle cells.
Am. J. Physiol.
265 (Cell Physiol. 34):
C1517-C1526,
1993
24.
Hirst, G. D. S.,
and
F. R. Edwards.
Sympathetic neuroeffector transmission in arteries and arterioles.
Physiol. Rev.
69:
546-604,
1989
25.
Javid, P. J.,
S. W. Watts,
and
R. C. Webb.
Inhibition of nitric oxide-induced vasodilation by gap junction inhibitors: a potential role for a cGMP-independent nitric oxide pathway.
J. Vasc. Res.
33:
395-404,
1996[Medline].
26.
Karaki, H.
Ca2+ regulation of vascular smooth muscle and release of endothelium-derived relaxing factor.
In: Ion Channels of Vascular Smooth Muscle Cells and Endothelial Cells, edited by N. Sperelakis,
and H. Kuriyama. New York: Elsevier, 1991, p. 297-315.
27.
Kimura, H.,
Y. Oyamada,
H. Ohshika,
M. Mori,
and
M. Oyamada.
Reversible inhibition of gap junctional intercellular communication, synchronous contraction, and synchronism of intracellular Ca2+ fluctuation in cultured neonatal rat cardiac myocytes by heptanol.
Exp. Cell Res.
220:
348-356,
1995[Medline].
28.
Largo, C.,
G. C. Tombaugh,
P. G. Aitken,
O. Herreras,
and
G. G. Somjen.
Heptanol but not fluoroacetate prevents the propagation of spreading depression in rat hippocampal slices.
J. Neurophysiol.
77:
9-16,
1997
29.
Macey, R. I.
Mathematical models of membrane transport processes.
In: Membrane Physiology, edited by T. E. Andrioli,
J. F. Hoffman,
and D. D. Fanestil. New York: Plenum, 1987, p. 111-130.
30.
Manchanda, R.,
and
K. Venkateswarlu.
Effects of heptanol on electrical activity in the guinea-pig vas deferens.
Br. J. Pharmacol.
120:
367-370,
1997[Medline].
31.
Massey, K. D.,
B. N. Minnich,
and
J. M. Burt.
Arachidonic acid and lipoxygenase metabolites uncouple neonatal rat cardiac myocyte pairs.
Am. J. Physiol.
263 (Cell Physiol. 32):
C494-C501,
1992
32.
Pappas, E.,
A. Rudisuli,
P. Maurer,
and
R. Weingart.
Effects of general anesthetics on current flow across membranes in guinea pig myocytes.
Am. J. Physiol.
256 (Cell Physiol. 25):
C273-C281,
1989
33.
Papas, C. A.,
M. G. Rioult,
and
B. R. Ransom.
Octanol, a gap junction uncoupling agent, changes intracellular [H+] in rat astrocytes.
Glia
16:
7-15,
1996[Medline].
34.
Peracchia, C.
Effects of the anesthetics heptanol, halothane and isoflurane on gap junction conductance in crayfish septate axons: a calcium- and hydrogen-independent phenomenon potentiated by caffeine and theophylline, and inhibited by 4-aminopyridine.
J. Membr. Biol.
121:
67-78,
1991[Medline].
35.
Serio, R.,
C. Barajas-Lopez,
E. E. Daniel,
I. Berezin,
and
J. D. Huizinga.
Slow-wave activity in colon: role of network of submucosal interstitial cells of Cajal.
Am. J. Physiol.
260 (Gastrointest. Liver Physiol. 23):
G636-G645,
1991
36.
Spray, D. C.,
and
J. M. Burt.
Structure-activity relationships of the cardiac gap junction channel.
Am. J. Physiol.
258 (Cell Physiol. 27):
C195-C205,
1990
37.
Takens-Kwak, B. R.,
H. J. Jongsma,
M. B. Rook,
and
A. C. Van Ginneken.
Mechanism of heptanol-induced uncoupling of cardiac gap junctions: a perforated patch-clamp study.
Am. J. Physiol.
262 (Cell Physiol. 31):
C1531-C1538,
1992
38.
Tasi, M. L.,
S. W. Watts,
R. Loch-Caruso,
and
R. C. Webb.
The role of gap junctional communication in contractile oscillations in arteries from normotensive and hypertensive rats.
J. Hypertens.
13:
1123-1133,
1995[Medline].
39.
Valiunas, V.,
F. F. Bukauskas,
and
R. Weingart.
Conductances and selective permeability of connexin43 gap junction channels examined in neonatal rat heart cells.
Circ. Res.
80:
708-719,
1997
40.
Watts, S. W.,
M. L. Tsai,
R. Loch-Caruso,
and
R. C. Webb.
Gap junctional communication and vascular smooth muscle reactivity: use of tetraethylammonium chloride.
J. Vasc. Res.
31:
307-313,
1994[Medline].
41.
Watts, S. W.,
and
R. C. Webb.
Vascular gap junctional communication is increased in mineralocorticoid-salt hypertension.
Hypertension
28:
888-893,
1996
42.
Weingart, R.,
and
F. F. Bukauskas.
Long-chain n-alkanols and arachidonic acid interfere with the Vm-sensitive gating mechanism of gap junction channels.
Pflügers Arch.
435:
310-319,
1998[Medline].
43.
Wolosin, J. M.,
O. A. Candia,
K. Peterson-Yantorno,
M. M. Civan,
and
X. P. Shi.
Effect of heptanol on the short circuit currents of cornea and ciliary body demonstrates rate limiting role of heterocellular gap junctions in active ciliary body transport.
Exp. Eye Res.
64:
945-952,
1997[Medline].
44.
Zhang, Y. M.,
M. Miura,
and
H. E. ter Keurs.
Triggered propagated contractions in rat cardiac trabeculae. Inhibition by octanol and heptanol.
Circ. Res.
79:
1077-1085,
1996
This article has been cited by other articles:
![]() |
Y. Takeda, S. M. Ward, K. M. Sanders, and S. D. Koh Effects of the gap junction blocker glycyrrhetinic acid on gastrointestinal smooth muscle cells Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G832 - G841. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, T. C. Resta, and B. R. Walker Disruption of smooth muscle gap junctions attenuates myogenic vasoconstriction of mesenteric resistance arteries Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2677 - H2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Solomon, K. H. Chon, and M. N. Rodriguez Blockade of Brain Stem Gap Junctions Increases Phrenic Burst Frequency and Reduces Phrenic Burst Synchronization in Adult Rat J Neurophysiol, January 1, 2003; 89(1): 135 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lagaud, V. Karicheti, Harm. J. Knot, G. J. Christ, and I. Laher Inhibitors of gap junctions attenuate myogenic tone in cerebral arteries Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2177 - H2186. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Kuebler, X. Ying, and J. Bhattacharya Mechanotransduction in the Lung: Pressure-induced endothelial Ca2+ oscillations in lung capillaries Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L917 - L923. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Z. Wang, N. Day, M. Valcic, K. Hsieh, S. Serels, P. R. Brink, and G. J. Christ Intercellular communication in cultured human vascular smooth muscle cells Am J Physiol Cell Physiol, July 1, 2001; 281(1): C75 - C88. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sauer, J. Hescheler, and M. Wartenberg Mechanical strain-induced Ca2+ waves are propagated via ATP release and purinergic receptor activation Am J Physiol Cell Physiol, August 1, 2000; 279(2): C295 - C307. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ashino, X. Ying, L. G. Dobbs, and J. Bhattacharya [Ca2+]i oscillations regulate type II cell exocytosis in the pulmonary alveolus Am J Physiol Lung Cell Mol Physiol, July 1, 2000; 279(1): L5 - L13. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Reinecke, G. H. MacDonald, S. D. Hauschka, and C. E. Murry Electromechanical Coupling between Skeletal and Cardiac Muscle: Implications for Infarct Repair J. Cell Biol., May 1, 2000; 149(3): 731 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schubert, P. G. Frank, B. Razani, D. S. Park, C.-W. Chow, and M. P. Lisanti Caveolae-deficient Endothelial Cells Show Defects in the Uptake and Transport of Albumin in Vivo J. Biol. Chem., December 21, 2001; 276(52): 48619 - 48622. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |